BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24288008)

  • 1. A tumor suppressor function for the lipid phosphatase INPP4B in melanocytic neoplasms.
    Perez-Lorenzo R; Gill KZ; Shen CH; Zhao FX; Zheng B; Schulze HJ; Silvers DN; Brunner G; Horst BA
    J Invest Dermatol; 2014 May; 134(5):1359-1368. PubMed ID: 24288008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INPP4B protects from metabolic syndrome and associated disorders.
    Zhang M; Ceyhan Y; Kaftanovskaya EM; Vasquez JL; Vacher J; Knop FK; Nathanson L; Agoulnik AI; Ittmann MM; Agoulnik IU
    Commun Biol; 2021 Mar; 4(1):416. PubMed ID: 33772116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes.
    Li Chew C; Lunardi A; Gulluni F; Ruan DT; Chen M; Salmena L; Nishino M; Papa A; Ng C; Fung J; Clohessy JG; Sasaki J; Sasaki T; Bronson RT; Hirsch E; Pandolfi PP
    Cancer Discov; 2015 Jul; 5(7):740-51. PubMed ID: 25883022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas.
    Chi MN; Guo ST; Wilmott JS; Guo XY; Yan XG; Wang CY; Liu XY; Jin L; Tseng HY; Liu T; Croft A; Hondermarck H; Scolyer RA; Jiang CC; Zhang XD
    Oncotarget; 2015 Nov; 6(37):39891-907. PubMed ID: 26573229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer.
    Gasser JA; Inuzuka H; Lau AW; Wei W; Beroukhim R; Toker A
    Mol Cell; 2014 Nov; 56(4):595-607. PubMed ID: 25458846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor.
    Kofuji S; Kimura H; Nakanishi H; Nanjo H; Takasuga S; Liu H; Eguchi S; Nakamura R; Itoh R; Ueno N; Asanuma K; Huang M; Koizumi A; Habuchi T; Yamazaki M; Suzuki A; Sasaki J; Sasaki T
    Cancer Discov; 2015 Jul; 5(7):730-9. PubMed ID: 25883023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML.
    Rijal S; Fleming S; Cummings N; Rynkiewicz NK; Ooms LM; Nguyen NY; Teh TC; Avery S; McManus JF; Papenfuss AT; McLean C; Guthridge MA; Mitchell CA; Wei AH
    Blood; 2015 Apr; 125(18):2815-24. PubMed ID: 25736313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia.
    Dzneladze I; He R; Woolley JF; Son MH; Sharobim MH; Greenberg SA; Gabra M; Langlois C; Rashid A; Hakem A; Ibrahimova N; Arruda A; Löwenberg B; Valk PJ; Minden MD; Salmena L
    Leukemia; 2015 Jul; 29(7):1485-95. PubMed ID: 25736236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INPP4B Is a Tumor Suppressor in the Context of PTEN Deficiency.
    Vo TT; Fruman DA
    Cancer Discov; 2015 Jul; 5(7):697-700. PubMed ID: 26152921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatment.
    Ip LR; Poulogiannis G; Viciano FC; Sasaki J; Kofuji S; Spanswick VJ; Hochhauser D; Hartley JA; Sasaki T; Gewinner CA
    Oncotarget; 2015 Apr; 6(12):10548-62. PubMed ID: 25868852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Transcriptional Landscape of Immune-Response 3'-UTR Alternative Polyadenylation in Melanoma.
    Yang X; Wu Y; Chen X; Qiu J; Huang C
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genes regulated by DNA methylation are involved in distinct phenotypes during melanoma progression and are prognostic factors for patients.
    Papaiz DD; Rius FE; Ayub ALP; Origassa CS; Gujar H; Pessoa DO; Reis EM; Nsengimana J; Newton-Bishop J; Mason CE; Weisenberger DJ; Liang G; Jasiulionis MG
    Mol Oncol; 2022 May; 16(9):1913-1930. PubMed ID: 35075772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INPP4B exerts a dual role in gastric cancer progression and prognosis.
    Wu Y; Wang X; Lu Y; Wang H; Wang M; You Y; Su X; Sun D; Sun Y; Li Y
    J Cancer; 2021; 12(23):7201-7213. PubMed ID: 34729121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer.
    Rodgers SJ; Ooms LM; Oorschot VMJ; Schittenhelm RB; Nguyen EV; Hamila SA; Rynkiewicz N; Gurung R; Eramo MJ; Sriratana A; Fedele CG; Caramia F; Loi S; Kerr G; Abud HE; Ramm G; Papa A; Ellisdon AM; Daly RJ; McLean CA; Mitchell CA
    Nat Commun; 2021 May; 12(1):3140. PubMed ID: 34035258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and functional characterization of INPP4B in gallbladder cancer patients and gallbladder cancer cells.
    Wu Y; Meng D; Xu X; Bao J; You Y; Sun Y; Li Y; Sun D
    BMC Cancer; 2021 Apr; 21(1):433. PubMed ID: 33879096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK.
    Tran KB; Kolekar S; Jabed A; Jaynes P; Shih JH; Wang Q; Flanagan JU; Rewcastle GW; Baguley BC; Shepherd PR
    BMC Cancer; 2021 Feb; 21(1):136. PubMed ID: 33549048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor types.
    Zhu MMT; Burugu S; Gao D; Yu J; Kos Z; Leung S; Horst BA; Nielsen TO
    Mod Pathol; 2020 Sep; 33(9):1753-1763. PubMed ID: 32350416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the duality of
    Mangialardi EM; Chen K; Salmon B; Vacher J; Salmena L
    Oncotarget; 2019 Oct; 10(59):6378-6390. PubMed ID: 31695845
    [No Abstract]   [Full Text] [Related]  

  • 19. INPP4B As A Prognostic And Diagnostic Marker Regulates Cell Growth Of Pancreatic Cancer Via Activating AKT.
    Zhai S; Liu Y; Lu X; Qian H; Tang X; Cheng X; Wang Y; Shi Y; Deng X
    Onco Targets Ther; 2019; 12():8287-8299. PubMed ID: 31632078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of cyclin F mRNA expression in the survival of skin melanoma patients: Comprehensive analysis of the pathways altered due to cyclin F upregulation.
    Gagat M; Krajewski A; Grzanka D; Grzanka A
    Oncol Rep; 2018 Jul; 40(1):123-144. PubMed ID: 29767233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.